Sundhedssektoren dækker alt fra forskning over medicin til sundhedssystemer. Sektoren kan opdeles i to kategorier: “Health Care Equipment and Services” - også kaldet “medico” - og “Pharmaceuticals, Biotechnology & Life Sciences”. Medicoindustrien består af selskaber, der udvikler, producerer og sælger medicinsk udstyr, mens “Pharmaceuticals, Biotechnology & Life Sciences”-kategorien består af store medicinalvirksomheder og biotekvirksomheder, der producerer forskellige former for lægemidler og medicinalvarer. I Danmark har vi en særligt veludviklet medicinalindustri med mange børsnoterede virksomheder, der både er veldrevne og sunde. Sundhedssektoren rummer store investeringsmuligheder, uanset om man er til defensive, langsigtede og sikre selskaber eller de nye og mere risikable selskaber med stort kurspotentiale.
Regnet på de 183 aktier i listen — som percentiler målt mod alle de aktier vi følger, ikke som karakterer. Genberegnes hver dag efter børslukning.
Hvad tallene siger i dag: Kvalitet: lav · Værdi: lav · Momentum: middel — målt som percentiler mod alle de aktier vi følger, ikke som karakterer. Flertallet af aktierne handler under deres egne gennemsnit lige nu. Spændet er stort — kvalitet går fra 0 til 100, så gennemsnittet dækker over meget forskellige selskaber.
| Aktie | Land | Kurs | Ændring |
|---|---|---|---|
| H Lundbeck A/S | Danmark | 41,30 | -5,92% |
| Bavarian Nordic A/S | Danmark | 200,60 | -1,18% |
| Bristol-Myers Squibb Company | USA | 63,73 | -0,59% |
| Drägerwerk AG & Co. KGaA | Tyskland | 85,60 | -0,23% |
| H Lundbeck A/S | Danmark | 41,80 | -6,40% |
| Orion Oyj | Finland | 79,30 | -0,50% |
| Humana AB (publ) | Sverige | 68,00 | +0,30% |
| Medtronic plc | USA | 93,68 | -0,13% |
| Attendo AB (publ) | Sverige | 122,40 | -0,33% |
| Getinge AB ser. B | Sverige | 238,10 | +0,04% |
| Halozyme Therapeutics, Inc | USA | 106,51 | -1,32% |
| Regeneron Pharmaceuticals, Inc | USA | 772,87 | -2,63% |
| Ambea AB | Sverige | 169,50 | +2,67% |
| Arjo AB (publ) | Sverige | 27,94 | +0,65% |
| Novo Nordisk A/S | USA | 42,45 | -2,31% |
| Amphastar P | USA | 23,58 | -1,38% |
| Demant A/S | Danmark | 295,40 | -0,94% |
| Pfizer Inc | USA | 27,48 | -0,88% |
| Johnson & Johnson | USA | 266,24 | -0,03% |
| Zealand Pharma A/S | Danmark | 276,90 | -0,65% |
| InMode Ltd | USA | 14,88 | -0,07% |
| Siemens Healthineers AG | Tyskland | 38,99 | 0,00% |
| Novo Nordisk A/S | Danmark | 276,15 | -1,52% |
| Synsam AB | Sverige | 53,80 | -0,37% |
| Ascendis Pharma A/S | USA | 236,15 | -10,86% |
| Vertex Pharmaceuticals Incorporated | USA | 513,64 | -1,13% |
| Biogen Inc | Tyskland | 166,36 | +2,98% |
| Henry Schein, Inc | USA | 87,45 | -1,66% |
| IQVIA Holdings Inc | USA | 269,78 | +1,55% |
| Roche Holding AG | Schweiz | 321,50 | +0,25% |
| Amgen Inc | USA | 375,76 | -1,51% |
| Sanofi ADR | USA | 42,52 | -1,87% |
| Merck KGaA | Tyskland | 131,20 | +0,50% |
| Centene Corporation | USA | 67,44 | -2,85% |
| Royalty Pharma plc | USA | 58,50 | -0,93% |
| Humana Inc | USA | 394,56 | -3,06% |
| Thermo Fisher Scientific Inc | USA | 639,33 | +4,19% |
| AbbVie Inc | USA | 261,59 | -0,07% |
| Illumina, Inc | USA | 223,94 | +7,55% |
| Viatris Inc | USA | 16,64 | -0,15% |
| Krystal Biotech, Inc | USA | 334,21 | -1,71% |
| QIAGEN N.V | USA | 42,72 | +2,01% |
| Globus Medical, Inc | USA | 74,78 | -1,31% |
| DaVita HealthCare Partners Inc | USA | 190,82 | +0,79% |
| Genmab A/S | Danmark | 2.134,00 | +0,85% |
| Cantargia AB | Sverige | 1,59 | -0,38% |
| CellaVision AB | Sverige | 161,00 | 0,00% |
| Eton Pharmaceuticals, Inc | USA | 54,59 | -5,26% |
| Eli Lilly and Company | USA | 1.134,79 | -0,31% |
| Novartis AG | USA | 138,79 | -0,14% |
| UnitedHealth Group Incorporated | USA | 376,25 | -1,90% |
| AstraZeneca PLC | Sverige | 1.593,50 | +0,09% |
| UCB SA | Belgien | 209,10 | -0,67% |
| HCA Healthcare, Inc | USA | 422,47 | -0,71% |
| BioPorto A/S | Danmark | 1,12 | -3,46% |
| McKesson Corporation | USA | 897,73 | -1,45% |
| Cardinal Health, Inc | USA | 232,62 | -0,97% |
| Swedish Orphan Biovitrum AB (publ) | Sverige | 441,40 | -1,52% |
| Embla Medical hf | Danmark | 27,10 | -0,37% |
| Bayer AG NA | Tyskland | 48,74 | -1,20% |
| Teva Pharma Industries Ltd ADR | USA | 39,03 | +0,80% |
| Harvard Bioscience, Inc | USA | 8,00 | -1,11% |
| Abbott Laboratories | USA | 102,07 | -0,99% |
| BioGaia AB (publ) | Sverige | 107,30 | 0,00% |
| Camurus AB | Sverige | 596,00 | +0,34% |
| ICON PLC | USA | 172,01 | +1,82% |
| BeiGene, Ltd. | USA | 347,87 | -1,68% |
| Almirall, S.A | Spanien | 10,52 | +2,53% |
| Boston Scientific Corporation | USA | 43,96 | -2,43% |
| Saniona AB | Sverige | 10,42 | +2,86% |
| Gilead Sciences, Inc | USA | 145,73 | -0,46% |
| BioMarin Pharmaceutical Inc | USA | 64,41 | -3,01% |
| Laboratorios Farmaceuticos Rovi, S.A | Spanien | 57,55 | +0,44% |
| Alcon Inc | USA | 67,79 | +0,07% |
| Coloplast A/S | Danmark | 418,40 | -0,19% |
| Tactile Systems Technology, Inc | USA | 22,53 | -0,18% |
| ChemoMetec A/S | Danmark | 481,60 | -0,29% |
| Sectra AB (publ) | Sverige | 296,00 | +0,75% |
| ALK-Abelló A/S | Danmark | 192,20 | -1,54% |
| Photocure ASA | Norge | 50,90 | -1,17% |
| BICO Group AB | Sverige | 20,55 | +0,24% |
| Galmed Pharmaceuticals Ltd | USA | 3,82 | -0,52% |
| Sarepta Therapeutics, Inc | USA | 20,75 | -0,84% |
| Bruker Corporation | USA | 55,91 | +6,17% |
| Ambu A/S | Danmark | 66,40 | -1,34% |
| Elekta AB (publ) | Sverige | 52,25 | +4,40% |
| Merck & Co., Inc | USA | 143,82 | -0,71% |
| Swedencare publ AB | Sverige | 22,25 | -0,45% |
| Intuitive Surgical, Inc | USA | 377,03 | -0,24% |
| Insulet Corporation | USA | 139,64 | +1,33% |
| Bonesupport Holding AB | Sverige | 216,60 | -2,26% |
| ArcticZymes Technologies ASA | Norge | 21,00 | +1,94% |
| Dynavox Group | Sverige | 73,15 | -0,75% |
| Sagimet Biosciences Inc. Series A Common Stock | USA | 10,34 | -5,01% |
| BrainCool AB | Sverige | 0,92 | +3,38% |
| Moberg Pharma AB (publ) | Sverige | 11,00 | -0,90% |
| GN Store Nord A/S | Danmark | 95,04 | +1,00% |
| Arcturus Therapeutics Holdings Inc | USA | 15,82 | +3,47% |
| Cybin Inc. Common Stock | USA | 13,30 | -2,28% |
| Iovance Biotherapeutics, Inc | USA | 9,36 | +1,03% |
| Dianthus Therapeutics Inc. | USA | 104,25 | -3,19% |
| RaySearch Laboratories AB (publ) | Sverige | 173,80 | +0,46% |
| AbCellera Biologics Inc | USA | 11,42 | +2,26% |
| ATAI Life Sciences BV | USA | 7,35 | 0,00% |
| Circio Holding ASA | Norge | 11,78 | -12,09% |
| Teladoc Inc | USA | 6,60 | +1,46% |
| GH RESEARCH PLC DL-025 | Tyskland | 23,20 | -3,33% |
| Mendus AB (publ) | Sverige | 6,54 | -4,80% |
| Moderna, Inc | USA | 142,95 | -2,55% |
| COMPASS Pathways plc | USA | 13,72 | -5,65% |
| Revolution Medicines, Inc | USA | 204,31 | -0,39% |
| So-Young International Inc | USA | 2,70 | +2,86% |
| Personalis, Inc | USA | 16,04 | -1,53% |
| GH Research PLC | USA | 27,57 | -1,15% |
| Aurora Cannabis Inc | USA | 3,82 | +0,15% |
| BioArctic AB (publ) | Sverige | 318,40 | -2,15% |
| Fate Therapeutics, Inc | USA | 2,38 | +1,71% |
| Pila Pharma AB | Sverige | 1,97 | -6,87% |
| Butterfly Network, Inc. | USA | 7,74 | +4,39% |
| BioNTech SE | USA | 96,72 | -2,17% |
| Infant Bacterial Therapeutics AB (publ) | Sverige | 65,90 | +1,38% |
| Valerio Therapeutics | Frankrig | 0,65 | -2,84% |
| Hansa Biopharma AB | Sverige | 37,98 | -4,48% |
| Scandinavian Medical Solutions A/S | Danmark | 2,50 | -6,72% |
| Tilray, Inc | USA | 3,99 | -3,74% |
| Pharma Equity Group A/S Cl A | Danmark | 0,09 | +9,75% |
| Novavax, Inc | USA | 9,23 | -3,81% |
| Century Therapeutics, Inc. Common Stock | USA | 1,96 | -2,00% |
| Tempus AI, Inc. Class A Common Stock | USA | 68,55 | +10,19% |
| CRISPR Therapeutics AG | USA | 51,76 | -2,27% |
| Vitrolife AB | Sverige | 90,95 | +0,66% |
| Denali Therapeutics Inc | USA | 20,45 | -3,63% |
| Zomedica Corp. | USA | 0,08 | -1,11% |
| Thor Medical ASA | Norge | 4,60 | -3,26% |
| Axsome Therapeutics, Inc | USA | 207,33 | -4,27% |
| Canopy Growth Corporation | USA | 0,92 | -1,75% |
| Geron Corporation | USA | 1,32 | -4,01% |
| Filana Therapeutics, Inc. | USA | 0,70 | -2,99% |
| Immunitybio Inc | USA | 7,96 | -4,96% |
| SoftOx Solutions AS | Norge | 0,11 | +0,93% |
| Biomea Fusion, Inc | USA | 1,76 | -1,12% |
| Acrivon Therapeutics Inc. Common Stock | USA | 1,82 | -7,40% |
| ExpreS2ion Biotech Holding AB | Sverige | 1,30 | +3,60% |
| Altimmune, Inc | USA | 3,24 | -1,82% |
| Nano-X Imaging Ltd | USA | 0,70 | -0,64% |
| Q linea AB | Sverige | 18,10 | -2,69% |
| StenoCare A/S | Danmark | 0,93 | +0,87% |
| Monsenso A/S | Danmark | 0,25 | 0,00% |
| AC Immune SA | USA | 2,69 | +0,94% |
| Recursion Pharmaceuticals, Inc | USA | 3,25 | -4,69% |
| BioInvent International AB | Sverige | 22,60 | +1,12% |
| Alzinova AB | Sverige | 0,46 | -1,83% |
| Editas Medicine, Inc | USA | 2,60 | -5,11% |
| Heron Therapeuti | USA | 0,32 | -0,03% |
| Fluoguide AS | Sverige | 33,20 | -1,48% |
| Viking Therapeutics, Inc | USA | 29,88 | -5,23% |
| XSpray Pharma AB | Sverige | 9,35 | 0,00% |
| ViroGates A/S | Danmark | 10,10 | -5,61% |
| Co-Diagnostics, Inc | USA | 1,14 | +2,70% |
| Summit Therapeutics Inc | USA | 17,49 | -5,05% |
| Acarix A/S | Sverige | 0,21 | -2,77% |
| Gossamer Bio, Inc | USA | 10,29 | -3,83% |
| Initiator Pharma A/S | Sverige | 2,29 | -2,55% |
| Bullfrog AI Holdings, Inc. Common Stock | USA | 0,44 | -6,37% |
| Anavex Life Sciences Corp | USA | 2,48 | -4,81% |
| Corbus Pharmaceuticals Holdings, Inc | USA | 6,87 | -14,98% |
| Evaxion Biotech A/S | USA | 3,05 | -0,65% |
| Gubra A/S | Danmark | 297,80 | -4,55% |
| AIM ImmunoTech Inc | USA | 0,22 | -3,54% |
| Sana Biotechnology, Inc | USA | 3,13 | -2,19% |
| Tenaya Therapeutics Inc. Common Stock | USA | 0,67 | -2,60% |
| Cardiff Oncology, Inc | USA | 1,32 | +0,38% |
| Northwest Biotherapeutics, Inc | USA | 0,17 | +1,64% |
| Lifecare AS | Norge | 0,28 | 0,00% |
| Inovio Pharmaceuticals, Inc | USA | 1,17 | -1,27% |
| Passage Bio, Inc | USA | 4,79 | -1,44% |
| Qlife Holding AB | Sverige | 1,65 | -0,24% |
| 2cureX AB | Sverige | 0,42 | -12,13% |
| Ocugen, Inc | USA | 1,00 | -5,96% |
| Faron Pharmaceuticals Oy | Finland | 0,41 | -0,24% |
| Xintela AB | Sverige | 0,16 | -0,94% |
| Oncopeptides AB | Sverige | 1,64 | +1,17% |
| Aptevo Therapeutics Inc | USA | 1,76 | -2,22% |